Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Therapeutics × 30 days × Clear all

Sponsor

Conditions

Head and Neck Neoplasms 2 Depression 2 Triple Negative Breast Neoplasms 1 Radiation Fibrosis Syndrome 1 Pain 1 Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Immune Checkpoint Inhibitor-Induced Dermatitis 1 Fatigue 1 Anxiety Disorders 1

Interventions

pembrolizumab 13 Nivolumab 9 Specimen Handling 8 Gemcitabine 8 Magnetic Resonance Spectroscopy 7 Carboplatin 7 enfortumab vedotin 6 Cisplatin 6 Docetaxel 5 sacituzumab govitecan 4 atezolizumab 4 durvalumab 3 avelumab 3 Taxes 3 Paclitaxel 3 Ipilimumab 3 tislelizumab 2 erdafitinib 2 cabozantinib 2 Radiosurgery 2 Platinum 2 CTLA-4 Antigen 2 zanidatamab 1 veliparib 1 urelumab 1 tremelimumab 1 tazemetostat 1 sapanisertib 1 relatlimab 1 olaparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡